Zurueck zur Suche

Reporte zur Charge U016975

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 5 PA 2 MI 2 VA 1

VAERS 2379310

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016975

mild
Staat
PA
Alter
5,0
Geschlecht
F
Eingang
22.07.2022
Impfdatum
20.07.2022
Beginn
20.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Body temperature increased Injection site erythema Injection site swelling

Symptomtext

Patients mother complains of swollen reddened area from both injection sites and a temperature of 100.8 Fahrenheit persistent over 48 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Mother said she was taking Ibuprofen
Allergien
none
Vorherige Impfungen
-

VAERS 1822177

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016975

mild
Staat
PA
Alter
4,0
Geschlecht
F
Eingang
27.10.2021
Impfdatum
25.10.2021
Beginn
25.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Injection site erythema Injection site swelling

Symptomtext

Mom walked in with pt earlier today for concern of redness and swelling at injection site. Mom states after her 4yr WCC and shots, mom took her home and gave a 'nice warm bath" and then she noted that her R upper back of arm started to "swell up'.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2239126

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016975

gering
Staat
MI
Alter
1,0
Geschlecht
M
Eingang
18.04.2022
Impfdatum
14.04.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

NONE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
URI one week prior
Vorgeschichte
no
Andere Medikamente
Albuterol PRN
Allergien
Amoxicillin
Vorherige Impfungen
-

VAERS 2141830

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016975

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
26.02.2022
Impfdatum
25.01.2022
Beginn
25.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event Product storage error

Symptomtext

No additional AE; PROQUAD was administered after a temperature excursion; This spontaneous report has been received from a nurse, concerning to a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies. On an unknown date, the with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD) underwent a temperature excursion of -14.1 grades Celsius (C) for a timeframe of 12 minutes (product storage error). There were no previous temperature excursions. Consequently, on 25-JAN-2022, the patient was vaccinated with the inappropriate storage Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD) at a dose of 0.5 milliliters (mL) (lot number U016975 has been verified to be a valid lot number, expiration date reported and established as 24-NOV-2022) as prophylaxis (formulation, strength, vaccination scheme, route of administration and anatomical location were not provided) (product storage error). No additional adverse events (AE) reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2141827

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016975

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
26.02.2022
Impfdatum
14.01.2022
Beginn
14.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE; the vaccine was administered after a temperature excursion; This spontaneous report was received from a nurse concerning a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, and previous drug reactions or allergies. On 14-JAN-2022, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD), at a dose of 0.5 milliliter (ml) (lot number U016975, which was verified to be a valid lot number, expiration date reported and upon internal validation established as 24-NOV-2022), as prophylaxis (route of administration, anatomical location and vaccination scheme were not reported) (product storage error). The administered vaccine experienced a temperature excursion of -14.1C during a time frame of 12 minutes. There was no previous temperature excursion. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2118363

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016975

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
17.02.2022
Impfdatum
-
Beginn
21.01.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; the vaccine was administered after a temperature excursion; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was administered a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, 0.5 milliliter, lot #U016975, expiration date: 24-NOV-2022 (strength and route of administration were not provided) for prophylaxis. The vaccine experienced a temperature excursion of -14.1 degrees Celsius for 12 minutes prior to being administered (Product storage error). There was no previous temperature excursion. No additional adverse event reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2095231

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016975

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
08.02.2022
Impfdatum
16.12.2021
Beginn
16.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE/none of these patients had any type of adverse reaction; Vaccines had temperature excursion on 12/14/2021. Vaccines were administered to unknown patients on unknovvn dates.//patient (...) was given PROQUAD in the right arm on 16-DEC-2021; This spontaneous report was received from a certified medical assistant and refers to a patient of unspecified age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 14-DEC-2021, prior to being administered, the vaccine experienced temperature excursion of 21 degrees Fahrenheit for 3 hours and 32 minutes. There was no previous temperature excursion reported. On 16-DEC-2021, the patient was administered a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant human albumin (rHA), lot #U016975, expiration date: 24-NOV-2022 in the right arm for prophylaxis (strength, dose, formulation and route of administration were not provided). (Improper storage of product in use) No additional adverse event was reported - it was reported that none of the patients had any type of adverse reaction (No adverse reaction). No further information is available. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2202USA000908: US-009507513-2202USA000907:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2084642

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016975

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
03.02.2022
Impfdatum
25.01.2022
Beginn
25.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE; Caller stated the vaccine was administered after a temperature excursion; This spontaneous report has been from a nurse concerning to a patient of unknown age and gender. No information was provided regarding the patients' medical history, concurrent conditions, drug or allergy history. No concomitant therapies were reported. On 25-JAN-2022, the patient was vaccinated with varicella measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) subcutaneous injection, 0.5 milliliter, (lot #U016975 and expiration date since it makes match with the autopopulated expiration date 14-NOV-2022) (strength, route of administration, and indication were not provided), which where stored at temperature excursion. The temperature excursion was - 14 degree Celsius for a time frame of 12 minutes. There was not previous temperature excursion. This is a one of several cases send for the same reporter.; Sender's Comments: US-009507513-2201USA007199: US-009507513-2201USA007340:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2082688

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016975

gering
Staat
MI
Alter
4,0
Geschlecht
F
Eingang
02.02.2022
Impfdatum
31.01.2022
Beginn
01.02.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Mass Skin warm Swelling

Symptomtext

swelling, large lump, hot to touch

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mass
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
Juice-Plus Vitamin
Allergien
NKA
Vorherige Impfungen
-

VAERS 1961058

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U016975

gering
Staat
NY
Alter
29,0
Geschlecht
F
Eingang
18.12.2021
Impfdatum
10.12.2021
Beginn
10.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Viral titre decreased

Symptomtext

No aditional AE details; An adult who was administered a PROQUAD dose due to "low titers" of mumps and varicella.; This spontaneous report has been received from a nurse practitioner referring to a 29-years-old female patient. The patient's pertinent medical history, concomitant therapies, and previous drug reactions or allergies were not reported. On 10-DEC-2021, the adult patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD), 0.5 ml (milliliter) subcutaneous for prophylaxis (Product administered to patient of inappropriate age) (lot number U016975 has been verified to be a valid lot number, the expiration date was reported and established as 24-NOV-2022; dose number, vaccination scheme, and anatomical site of vaccination were not reported) due to low titers of mumps and varicella. No additional AE details reported. .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Viral titre decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-